(Q42981208)

12 November 2017

title

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

2

1 reference

12 November 2017

7

1 reference

12 November 2017

Francisco Borrás-Cuesta

6

object named as

Borrás-Cuesta F

1 reference

12 November 2017

Bruña-Romero O

1

1 reference

12 November 2017

Wilkinson G

3

1 reference

12 November 2017

Grace K

4

1 reference

12 November 2017

Clarke B

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

12 November 2017

1 reference

12 November 2017

volume

25

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

470-477

1 reference

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Peptide-induced antiviral protection by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Vaccinia virus: a tool for research and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

A new technique for the assay of infectivity of human adenovirus 5 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Vaccination of chimpanzees against infection by the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Viral mutations, TCR antagonism and escape from the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Adenovirus-mediated gene transfer for cystic fibrosis: Part A. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Emerging principles for the recognition of peptide antigens by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250236

7 January 2021

Identifiers

DOI

10.1002/HEP.510250236

1 reference

12 November 2017

1 reference